Simple Blood Test May Predict Women's Fertility



Simple Blood Test May Predict a Blood Cancer's Return

Results might help doctors decide which patients need a stem cell transplant after chemo.

By Alan Mozes, HealthDay News

Don't Miss This

Sign Up for OurCancer Care and PreventionNewsletter

Thanks for signing up!You might also like these other newsletters:

The investigators said the test found evidence of a high risk for disease recurrence in 15 percent of the tested samples.
The investigators said the test found evidence of a high risk for disease recurrence in 15 percent of the tested samples.
iStock.com

British researchers say a simple blood test may be a cheap, easy and effective way to spot risk of recurrence of a common form of acute myeloid leukemia (AML).

This type of AML is characterized by a mutation in the NPM1 gene. A third of AML patients have this form of the deadly blood and bone marrow cancer.

Despite aggressive chemotherapy, a certain percentage of patients with this mutated gene will see their disease return. And many would benefit from a pre-emptive, lifesaving bone marrow transplant -- sometimes called stem cell transplantation, the researchers noted.

But a transplant ultimately destroys not only the marrow's cancerous cells but healthy tissue as well. So, doctors have long sought a reliable way of separating those in true need of a transplant from those who would likely fare well without one, the researchers said.

The problem: Accurately pinpointing the highest-risk patients has proven difficult, with doctors typically forced to rely on costly and time-consuming genetic testing of extracted tumor tissue.

Enter the so-called "Minimal Residual Disease" (MRD) test.

MRD testing is designed to help doctors screen for patients whose post-chemotherapy blood contains a telltale sign of the NPM1 gene mutation. Those who have that sign are at high risk for recurrence of the leukemia, and need a transplant, the researchers explained.

The test is now being used in a number of European countries, said study author Dr. David Grimwade. He is a professor of molecular haematology in the department of medical and molecular genetics with the Cancer Genetics Lab at King's College London.

"We are using it to guide transplantation in the current U.K. national trial for younger adults with AML," he said.

RELATED: 10 Essential Facts About Leukemia

Grimwade and his colleagues tried the test (which is not yet approved for use in the United States) on more than 2,500 blood samples obtained from nearly 350 patients with the NPM1 mutation.

At the same time, standard genetic testing was conducted on almost 275 other blood samples.

"Our key finding," said Grimwade, "is that the MRD test -- which is pretty cheap and easy to apply -- provides a much more powerful predictor of patient outcome in this group of AML patients as compared to genetic profiling of the tumor sample, which is a much more expensive test."

The investigators said the test found evidence of a high risk for disease recurrence in 15 percent of the tested samples, following a second round of chemotherapy. Finding that evidence suggested a more than 80 percent chance of disease recurrence after three years. This compared with just a 30 percent risk of disease recurrence among the other AML patients.

The study findings were published in the Jan. 21 issue of the New England Journal of Medicine.

In the end, Grimwade said his team concluded that the MRD test "provides a far stronger predictor of patient outcome than the standard tests used to determine whether a patient should have a stem cell transplant or not. We also show that serial MRD testing after completion of therapy can pinpoint precisely which patients are destined to relapse, allowing the opportunity for early intervention preventing full-blown relapse from occurring."

Dr. Michael Burke, author of an accompanying editorial in the journal, said the finding is important given that "a relapse in AML is almost certain death."

"And this study," he added, "points out that you can actually follow very, very low levels of leukemia using this NPM1 marker, and that those patients in whom it disappears after a couple of cycles of chemo will do exceedingly well. They don't need a bone marrow transplant. But those with high levels of this marker after two rounds of chemo fare terribly and really should go on to have the transplant. So, this is very encouraging news."

Burke is director of the Leukemia Lymphoma Program at the Children's Hospital of Wisconsin in Milwaukee.






Video: Simple blood test may predict recurrence of some breast cancers

Simple Blood Test May Predict a Blood Cancers Return
Simple Blood Test May Predict a Blood Cancers Return images

2019 year
2019 year - Simple Blood Test May Predict a Blood Cancers Return pictures

Simple Blood Test May Predict a Blood Cancers Return forecast
Simple Blood Test May Predict a Blood Cancers Return forecasting photo

Simple Blood Test May Predict a Blood Cancers Return pictures
Simple Blood Test May Predict a Blood Cancers Return pictures

Simple Blood Test May Predict a Blood Cancers Return Simple Blood Test May Predict a Blood Cancers Return new pictures
Simple Blood Test May Predict a Blood Cancers Return new images

images Simple Blood Test May Predict a Blood Cancers Return
pictures Simple Blood Test May Predict a Blood Cancers Return

Watch Simple Blood Test May Predict a Blood Cancers Return video
Watch Simple Blood Test May Predict a Blood Cancers Return video

Discussion on this topic: Simple Blood Test May Predict a Blood , simple-blood-test-may-predict-a-blood/
Discussion on this topic: Simple Blood Test May Predict a Blood , simple-blood-test-may-predict-a-blood/ , simple-blood-test-may-predict-a-blood/

Related News


21 Day Sugar Detox Diet Plan (Restart Your Body)
Women Who Win – We work on our mindsets, as well as our moves’
3 Ways to Play Netball
How Going Vegan Cleared My Skin and Gave Me Energy, by Lucy Watson
3 New Colour Combinations Everyones Wearing on Instagram
20 Amazing Holiday MakeupPalettes
How to get soft clear skin with natural kitchen ingredients at home
How to Tell the Difference Between Tourettes Syndrome and Transient Tic Disorder
Jonathan Saunders SS14 – London Collections: MEN
Australian woman in a coma has awoken to discover she is a mother
100 Years of Women’s Sneakers



Date: 16.12.2018, 08:40 / Views: 63185